Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-11Clinical Trial Update: Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring [Phase 1]
Phase 1 clinical trial evaluating whether counseling and feedback from continuous glucose monitoring can influence physical activity behavio…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
A completed clinical trial evaluated switching type 2 diabetes patients from a sulfonylurea with metformin to a glyburide/metformin combinat…
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin [Phase 3]
A Phase 3 trial evaluating metformin for peripheral and coronary endothelial dysfunction in patients with type 2 diabetes mellitus has been …
-
FDA approval · 2007-10-01FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a pioglitazone and glimepiride fixed-dose combination from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2007-09-27Clinical Trial Update: Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial update reports that chronic treatment with benfotiamine restores endothelial function in people with Type 2 diabete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-09-26FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA supplemental application approval for a fixed-dose combination of pioglitazone and glimepiride, filed by Prasco Laboratories.
-
FDA approval · 2007-09-26FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) from Takeda Pharmaceuticals America,…
-
CLINICAL_TRIALS research · 2007-09-20Clinical Trial Update: Dietary Interventions in Type 2 Obese Diabetic Patients in the Community [Phase 3]
Phase 3 clinical trial update on dietary interventions in obese patients with Type 2 diabetes; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phenomix completed a randomized, double-blind, placebo-controlled Phase 2 study of PHX1149 in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 [Phase 2]
Phase 2 clinical trial update assessing the glucose-lowering effect, safety and tolerability of CS-917 in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: Acute Effects of Sildenafil on Endothelial Function in People With Diabetes [Phase 3]
A Phase 3 trial evaluated the acute effects of sildenafil on endothelial function in adults with Type 2 diabetes mellitus; the study is comp…
-
FDA approval · 2007-09-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2007-09-10Clinical Trial Update: Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient [NA]
A completed clinical trial evaluating the influence of telemedicine on follow-up care for patients with type 2 diabetes mellitus.
-
FDA approval · 2007-09-07FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. This action updates th…
-
FDA approval · 2007-09-06FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Pioglitazone and Glimepiride from Prasco Laboratories to market a fixed-dose combination product…
-
FDA approval · 2007-09-06FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2007-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro mix 50/50) from Eli Lilly, authorizing the KwikPen deli…
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company. The action involves an additional …
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes [Phase 2, Phase 3]
An update on fenofibrate for dyslipidemia and metformin-controlled diabetes from Phase 2/Phase 3 trials; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia [Phase 3]
This clinical trial update reports the completion of a Phase 3 acceptability study evaluating a fixed-dose combination of fenofibrate 80 mg …
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes
A completed trial compared nighttime administration and hypoglycemia risk between insulin glargine and NPH insulin in people with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition [Phase 4]
A Phase 4 clinical trial investigates whether achieving very low LDL cholesterol with statin therapy influences steroidogenesis and cognitiv…